Results for “ ”

Entry Author Date Location
Akebia Merges With Keryx as Anemia Drug Race Nears Finish Line 06/28/18 Boston
The 2018 Xconomy Awards Finalists Are… 06/28/18 Boston
Precision Bio Lands $110M as Gene-Edited Cell Therapy Nears Clinic 06/27/18 Raleigh Durham
GBT Eyes Fast Nod for Sickle Cell Drug but Won’t Use Patient-Reported Data 06/27/18 San Francisco
Summit Therapeutics Ditches Duchenne Drug In Wake of Phase 2 Failure 06/27/18 Boston
Largest Startup Class Yet Enters UC Berkeley’s Expanding Accelerator 06/27/18 San Francisco
Cibus Raises $70M for Marketing of Gene-Edited Canola, More R&D 06/27/18 San Diego
AstraZeneca’s PARP Drug Is First to Help New Ovarian Cancer Patients 06/27/18 National
Don’t Be Boston 2.0, And Photos From “Bringing Back the Expats” 06/27/18 New York
Senators Grill HHS’s Azar on Drug Price Cuts That Have Yet to Come 06/26/18 National
Helix Expands Real-World and Online Footprint with HumanCode Deal 06/26/18 San Francisco
Catalog Hauls In $9M to Make DNA-Based Data Storage Commercially Viable 06/26/18 Boston
Skyhawk Lands $100M from Funding & Celgene Pact for RNA-Targeted Drugs 06/26/18 Boston
Bio-Techne to Acquire Liquid Biopsy Firm Exosome Diagnostics for $250M 06/25/18 Boston
Akero Closes $65M Financing to Back Liver Drug Licensed from Amgen 06/25/18 Boston
With Roche Data, Cancer Combos Post First Win Vs. Small Cell Lung Cancer 06/25/18 San Francisco
Bio Roundup: Duchenne Data, Roche Buys Foundation, IPO Wave & More 06/22/18 National
Bio IPO Madness: Six Biotech Startups Raise $568M in 24 Hours 06/21/18 National
What’s Hot in Seattle Biotech: Tech, Life Sciences Convergence & More 06/19/18 Seattle
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine 06/19/18 Boston
Sarepta’s Data Are First in Rush for Duchenne Gene Therapy 06/19/18 Boston
Emulate Adds $36M to Expand “Organ Chip” Drug Research Technology 06/19/18 Boston
Decibel Hauls in $55M to Bring Multiple Hearing Drugs to the Clinic 06/19/18 Boston
As Sarepta Preps Data, FDA Lifts Hold on Solid’s Duchenne Gene Therapy 06/18/18 Boston
Biotech Beware, Your Culture Is Showing 06/15/18 Boston
Teva’s Migraine Drug Fails in Phase 3 for Chronic Cluster Headaches 06/15/18 National
Bio Roundup: Not-BIO Party Foul, CRISPR Drama, Sickle Cell Updates 06/15/18 National
For Sickle Cell, a Complex Disease, New Drugs Could Bring Complex Costs 06/15/18 San Francisco
Bluebird’s Upgraded Gene Therapy Shows Promise For Sickle Cell Patients 06/15/18 Boston
Benchling Scores $14.5M to Grow Online Lab Notebook for Bio-Researchers 06/14/18 San Francisco
Page 2 of 350 « previous page · next page »